Sandoz initiates two more Phase III biosimilar trials, reinforcing long-term global leadership commitment
19 January 2012 | By Novartis
Sandoz announced that it has initiated two milestone Phase III clinical trials...
List view / Grid view
News
AstraZeneca and Bristol-Myers Squibb receive complete response letter from US FDA for dapagliflozin
19 January 2012 | By AstraZeneca
The FDA has issued a complete response letter regarding dapagliflozin...
Abbott’s STARLIMS LIMS technology to be installed in FDA testing laboratories
18 January 2012 | By Abbott
The U.S. FDA will begin implementing Abbott’s STARLIMS® software-based laboratory information management system...
U.S. Food and Drug Administration approves new formulations of Viread® for use by children living with HIV
18 January 2012 | By Gilead Sciences Inc
Gilead Sciences, Inc. announced that the U.S. FDA has approved Viread®...
Brazil Introduces Inactivated Polio Vaccine in National Immunization Program with Sanofi Pasteur Vaccine
18 January 2012 | By Sanofi Pasteur
Brazil has chosen to introduce injectable polio vaccine in its national immunization program...
Roy D. Baynes, MD, PhD, to join Gilead Sciences as Senior Vice President, Oncology Therapeutics
18 January 2012 | By Gilead Sciences
Gilead Sciences, Inc. announced that Roy D. Baynes, MD, PhD, will join the company...
First Hepatitis C treatment data demonstrating proof of principle with direct-acting antiviral-only therapy published
18 January 2012 | By Bristol-Myers Squibb Company
Full results from a Phase II clinical trial...
Daiichi Sankyo receives approval in Japan to market RANMARK®
18 January 2012 | By Daiichi Sankyo
RANMARK (denosumab), a treatment for bone complications stemming from multiple myeloma and bone metastases from solid tumors...
Novartis receives approval for Lucentis® and launches Galvus® in China
18 January 2012 | By Novartis
Novartis has received regulatory approval in China from the SFDA for Lucentis® (ranibizumab)...
Genzyme announces European approval of Framingham manufacturing plant
18 January 2012 | By Sanofi
Sanofi & Genzyme announced that the EMA has approved its manufacturing plant in Framingham....
Gilead Sciences completes acquisition of Pharmasset, Inc.
17 January 2012 | By Gilead Sciences Inc
Gilead Sciences, Inc. announced the completion to acquire Pharmasset, Inc...
FOSS releases new features for Vision
17 January 2012 | By FOSS NIRSystems, Inc.
Service Pack 7 has been released for Vision 3.50, a software package designed for use with the FOSS NIRSystems Near-Infrared laboratory and process analyzers...
Medivation and Pfizer announce results from Phase 3 Concert trial of dimebon in Alzheimer’s disease
17 January 2012 | By Pfizer
Dimebon did not meet primary efficacy endpoints...
Pan-European stroke prevention in atrial fibrillation registry – PREFER in AF – enrols first patient
16 January 2012 | By Weber Shandwick
Enrolment of the first patient into the PREvention oF thromboembolic events...
Lundbeck awarded prize for world-class production
16 January 2012 | By H. Lundbeck A/S
H. Lundbeck A/S has crowned six years of focused efforts on productivity improvements with a silver medallion...
